[
  {
    "ts": null,
    "headline": "These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth",
    "summary": "As the healthcare sector lags broader markets, AbbVie’s innovation in immunology and Johnson & Johnson’s MedTech expansion make these dividend giants standout bargains at below-market valuations",
    "url": "https://finnhub.io/api/news?id=bf0cc8151778e649dcea9c0f4d418f6a3cd309b59190c7c71b51e440a38e9881",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756409527,
      "headline": "These 2 Healthcare Stocks Are Even Better Bargain Buys Than UnitedHealth",
      "id": 136569077,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "As the healthcare sector lags broader markets, AbbVie’s innovation in immunology and Johnson & Johnson’s MedTech expansion make these dividend giants standout bargains at below-market valuations",
      "url": "https://finnhub.io/api/news?id=bf0cc8151778e649dcea9c0f4d418f6a3cd309b59190c7c71b51e440a38e9881"
    }
  },
  {
    "ts": null,
    "headline": "Commentary: Trump’s trade war is hurting most sectors of the economy",
    "summary": "The latest round of earnings reports revealed widespread damage from the Trump tariffs and other attacks on trade.",
    "url": "https://finnhub.io/api/news?id=f79d96aa415027377d39121c37660b242b4665192144f64a93b39b1515e24fdb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756408626,
      "headline": "Commentary: Trump’s trade war is hurting most sectors of the economy",
      "id": 136563635,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The latest round of earnings reports revealed widespread damage from the Trump tariffs and other attacks on trade.",
      "url": "https://finnhub.io/api/news?id=f79d96aa415027377d39121c37660b242b4665192144f64a93b39b1515e24fdb"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.",
    "summary": "They’re bargains right now, according to two key measures. Expert Jim Paulsen won’t venture a guess when the prices will recover.",
    "url": "https://finnhub.io/api/news?id=fd4eb00bd44731e8992d76e1c0275a4fb0d913031c03485e261f075be376c8b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756406460,
      "headline": "Healthcare Stocks Are ‘Priced at Panic Levels.’ It’s Time to Buy.",
      "id": 136563715,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "They’re bargains right now, according to two key measures. Expert Jim Paulsen won’t venture a guess when the prices will recover.",
      "url": "https://finnhub.io/api/news?id=fd4eb00bd44731e8992d76e1c0275a4fb0d913031c03485e261f075be376c8b7"
    }
  },
  {
    "ts": null,
    "headline": "Equillium: Pushing Forward With AhR Activation Drug Candidate EQ504 For UC",
    "summary": "Equillium, Inc. raises $50M to advance EQ504, a novel AhR modulator for ulcerative colitis. Phase 1 trials begin mid-2026. Click for more on EQ stock prospects.",
    "url": "https://finnhub.io/api/news?id=05298a6821a423e89829c846031602b35461c0b7ef1f4908cbbbf3f55e837930",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756402506,
      "headline": "Equillium: Pushing Forward With AhR Activation Drug Candidate EQ504 For UC",
      "id": 136564670,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2228863093/image_2228863093.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Equillium, Inc. raises $50M to advance EQ504, a novel AhR modulator for ulcerative colitis. Phase 1 trials begin mid-2026. Click for more on EQ stock prospects.",
      "url": "https://finnhub.io/api/news?id=05298a6821a423e89829c846031602b35461c0b7ef1f4908cbbbf3f55e837930"
    }
  },
  {
    "ts": null,
    "headline": "Merck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue?",
    "summary": "Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=354eaf3358c29b0fd80d89620888cdce5a4e2f585181267fbf6682ab16d186fe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756395009,
      "headline": "Merck (MRK) Up 2.8% Since Last Earnings Report: Can It Continue?",
      "id": 136563721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=354eaf3358c29b0fd80d89620888cdce5a4e2f585181267fbf6682ab16d186fe"
    }
  },
  {
    "ts": null,
    "headline": "Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?",
    "summary": "Pfizer braces for patent losses, IRA pressure and COVID uncertainty, but cost cuts and key drugs may still support profit growth.",
    "url": "https://finnhub.io/api/news?id=a72c3586afaa7ece6e70f2b2971d4a5c05086bda0c20505f68b074db1b0e3903",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756387320,
      "headline": "Can Pfizer's Cost Cuts and New Drugs Offset Upcoming Headwinds?",
      "id": 136560799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pfizer braces for patent losses, IRA pressure and COVID uncertainty, but cost cuts and key drugs may still support profit growth.",
      "url": "https://finnhub.io/api/news?id=a72c3586afaa7ece6e70f2b2971d4a5c05086bda0c20505f68b074db1b0e3903"
    }
  },
  {
    "ts": null,
    "headline": "AMDR Applauds Federal Court Decision to Bar Johnson & Johnson’s Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment",
    "summary": "WASHINGTON, August 28, 2025--The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a permanent injunction against Johnson & Johnson’s (NYSE: JNJ) Biosense Webster (BSW) medical device unit for unlawful, anti-competitive conduct. The ruling prohibits BSW from blocking hospitals’ access to safe, lower-cost, FDA-regulated reprocessed cardiac catheters. The decision follows a jury verdict or",
    "url": "https://finnhub.io/api/news?id=1621fe75370035db2f5ea746c54379172e09d9d4687ffd7d00ab74113c8aa2ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756382400,
      "headline": "AMDR Applauds Federal Court Decision to Bar Johnson & Johnson’s Biosense Webster Unit from Further Violation of Anti-Trust Laws in a Win for Hospitals, Patients, and the Environment",
      "id": 136557760,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "WASHINGTON, August 28, 2025--The Association of Medical Device Reprocessors (AMDR) announced that Judge James Selna of the U.S. District Court for the Central District of California has issued a permanent injunction against Johnson & Johnson’s (NYSE: JNJ) Biosense Webster (BSW) medical device unit for unlawful, anti-competitive conduct. The ruling prohibits BSW from blocking hospitals’ access to safe, lower-cost, FDA-regulated reprocessed cardiac catheters. The decision follows a jury verdict or",
      "url": "https://finnhub.io/api/news?id=1621fe75370035db2f5ea746c54379172e09d9d4687ffd7d00ab74113c8aa2ea"
    }
  },
  {
    "ts": null,
    "headline": "J&J removes some Abiomed heart pump controllers from market",
    "summary": "Abiomed reported one death associated with a pump driver circuit assembly that does not meet current specifications. The recall affects 69 controllers, a J&J spokesperson said.",
    "url": "https://finnhub.io/api/news?id=048719ad2e147bc1baeebdfba730ad9fffbbf44ef08eda5845a72c4cacb040c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756379475,
      "headline": "J&J removes some Abiomed heart pump controllers from market",
      "id": 136560808,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Abiomed reported one death associated with a pump driver circuit assembly that does not meet current specifications. The recall affects 69 controllers, a J&J spokesperson said.",
      "url": "https://finnhub.io/api/news?id=048719ad2e147bc1baeebdfba730ad9fffbbf44ef08eda5845a72c4cacb040c5"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equity And Income Fund Q2 2025 Commentary",
    "summary": "Stock selection information technology, communication services and consumer staples contributed to relative performance. Read more here.",
    "url": "https://finnhub.io/api/news?id=b26a21a1b62dcf7fd6c3a458f936f373d724121e85101d5c9253906b13f927d2",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756365300,
      "headline": "Invesco Equity And Income Fund Q2 2025 Commentary",
      "id": 136557079,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2187991365/image_2187991365.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Stock selection information technology, communication services and consumer staples contributed to relative performance. Read more here.",
      "url": "https://finnhub.io/api/news?id=b26a21a1b62dcf7fd6c3a458f936f373d724121e85101d5c9253906b13f927d2"
    }
  }
]